Subcutaneous Drug Delivery Devices Global Market Report 2024

Description

Subcutaneous drug delivery devices are medical devices designed to administer medications directly into the subcutaneous tissue, which is the layer of fat and connective tissue just beneath the skin. These devices are employed for delivering various drugs, including insulin, hormones, and biologics, offering a convenient and minimally invasive method of administration.

The main types of subcutaneous drug delivery devices include insulin pens, pen needles, injector pens, auto-injectors, and implantable pumps. Insulin pens are handheld devices used for precise and convenient insulin administration in diabetes management, enabling users to easily measure and inject doses. These devices are used in various applications, such as diabetes, fertility, and oncology, and are utilized by different end-users, including hospitals, clinics, homecare settings, and ambulatory surgical centers.

The subcutaneous drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides subcutaneous drug delivery devices market statistics, including subcutaneous drug delivery devices industry global market size, regional shares, competitors with a subcutaneous drug delivery devices market share, detailed subcutaneous drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the subcutaneous drug delivery devices industry. This subcutaneous drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The subcutaneous drug delivery devices market size has grown strongly in recent years. It will grow from $25.78 billion in 2023 to $27.66 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases, a growing demand for self-administration of drugs, rising rates of diabetes and obesity, patient preference for convenient treatments, and the expanding geriatric population.

The subcutaneous drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $36.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. The growth projected for the forecast period can be attributed to the expansion of the biologics and biosimilars market, increasing adoption of wearable drug delivery systems, the growth of personalized medicine, improvements in healthcare reimbursement policies, and a growing emphasis on home healthcare. Key trends expected include the integration of digital health technologies, the development of smart and connected devices, a rise in minimally invasive procedures, advancements in needle-free injection systems, and the emergence of artificial intelligence in device development.

The growing prevalence of diabetes and cardiovascular diseases (CVD) is expected to drive the expansion of the subcutaneous drug delivery devices market. The rise in these conditions is largely due to aging populations, poor diets, sedentary lifestyles, obesity, socioeconomic disparities, stress, environmental factors, and limited access to preventive healthcare. Subcutaneous drug delivery devices are widely used in diabetes management to administer insulin and other medications for glycemic control, as well as in CVD to deliver drugs like anticoagulants or lipid-lowering agents, offering a convenient and controlled way to manage these chronic diseases. For example, in April 2023, the British Diabetic Association, a UK-based charity, reported that 4.3 million people in the UK are currently living with diabetes, with new diagnoses increasing by 148,951 from 2020-21 to 2021-22. Additionally, over 2.4 million people in the UK are at high risk of developing type 2 diabetes. Furthermore, in May 2024, the Centers for Disease Control and Prevention (CDC) in the U.S. revealed that heart disease caused 702,880 deaths in 2022, accounting for 1 in every 5 deaths. As a result, the rising prevalence of diabetes and cardiovascular diseases is driving the growth of the subcutaneous drug delivery devices market.

Key players in the subcutaneous drug delivery device market are concentrating on developing advanced products such as miniature digital liquid flow sensors to improve the safety and accuracy of drug delivery. These sensors provide precise measurements of liquid flow rates and are especially useful for large-volume injectors. For instance, in May 2024, Sensirion AG, a Switzerland-based provider of environmental and flow sensors, introduced the SLD3x series sensor platform. This series includes highly accurate digital liquid flow sensors with customizable features, enabling precise flow measurement, occlusion detection, air bubble identification, and liquid temperature monitoring. These miniature sensors are suitable for large-scale medical device production, ensuring optimal dosing and enhanced patient safety in subcutaneous drug delivery.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc. for $0.960 billion. This acquisition aims to enhance Halozyme's biopharmaceutical capabilities by incorporating Antares' innovative drug delivery technologies and expanding its portfolio. The goal is to improve patient outcomes and accelerate the global development of Halozyme's ENHANZE technology. Antares Pharma Inc., also based in the US, specializes in subcutaneous drug delivery devices.

Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.

North America was the largest region in the subcutaneous drug delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the subcutaneous drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The subcutaneous drug delivery devices market consists of sales of needles, cartridges, and reservoirs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Subcutaneous Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on subcutaneous drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for subcutaneous drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The subcutaneous drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Insulin Pens; Pen Needles; Injector Pens; Auto-Injectors; Implantable Pumps
2) By Application: Diabetes; Fertility; Oncology
3) By End-User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers
Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Roche Holdings Inc.; Medtronic plc; Eli Lilly and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20878

1. Executive Summary

2. Subcutaneous Drug Delivery Devices Market Characteristics

3. Subcutaneous Drug Delivery Devices Market Trends And Strategies

4. Subcutaneous Drug Delivery Devices Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Subcutaneous Drug Delivery Devices Market Size and Growth

5.1. Global Subcutaneous Drug Delivery Devices Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Subcutaneous Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Subcutaneous Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Subcutaneous Drug Delivery Devices Market Segmentation

6.1. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Insulin Pens
Pen Needles
Injector Pens
Auto-Injectors
Implantable Pumps
6.2. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Diabetes
Fertility
Oncology
6.3. Global Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Homecare Settings
Ambulatory Surgical Centers

7. Subcutaneous Drug Delivery Devices Market Regional And Country Analysis

7.1. Global Subcutaneous Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Subcutaneous Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Subcutaneous Drug Delivery Devices Market

8.1. Asia-Pacific Subcutaneous Drug Delivery Devices Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Subcutaneous Drug Delivery Devices Market

9.1. China Subcutaneous Drug Delivery Devices Market Overview
9.2. China Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Subcutaneous Drug Delivery Devices Market

10.1. India Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Subcutaneous Drug Delivery Devices Market

11.1. Japan Subcutaneous Drug Delivery Devices Market Overview
11.2. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Subcutaneous Drug Delivery Devices Market

12.1. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Subcutaneous Drug Delivery Devices Market

13.1. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Subcutaneous Drug Delivery Devices Market

14.1. South Korea Subcutaneous Drug Delivery Devices Market Overview
14.2. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Subcutaneous Drug Delivery Devices Market

15.1. Western Europe Subcutaneous Drug Delivery Devices Market Overview
15.2. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Subcutaneous Drug Delivery Devices Market

16.1. UK Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Subcutaneous Drug Delivery Devices Market

17.1. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Subcutaneous Drug Delivery Devices Market

18.1. France Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Subcutaneous Drug Delivery Devices Market

19.1. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Subcutaneous Drug Delivery Devices Market

20.1. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Subcutaneous Drug Delivery Devices Market

21.1. Eastern Europe Subcutaneous Drug Delivery Devices Market Overview
21.2. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Subcutaneous Drug Delivery Devices Market

22.1. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Subcutaneous Drug Delivery Devices Market

23.1. North America Subcutaneous Drug Delivery Devices Market Overview
23.2. North America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Subcutaneous Drug Delivery Devices Market

24.1. USA Subcutaneous Drug Delivery Devices Market Overview
24.2. USA Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Subcutaneous Drug Delivery Devices Market

25.1. Canada Subcutaneous Drug Delivery Devices Market Overview
25.2. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Subcutaneous Drug Delivery Devices Market

26.1. South America Subcutaneous Drug Delivery Devices Market Overview
26.2. South America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Subcutaneous Drug Delivery Devices Market

27.1. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Subcutaneous Drug Delivery Devices Market

28.1. Middle East Subcutaneous Drug Delivery Devices Market Overview
28.2. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Subcutaneous Drug Delivery Devices Market

29.1. Africa Subcutaneous Drug Delivery Devices Market Overview
29.2. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Subcutaneous Drug Delivery Devices Market Competitive Landscape And Company Profiles

30.1. Subcutaneous Drug Delivery Devices Market Competitive Landscape
30.2. Subcutaneous Drug Delivery Devices Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Sanofi S.A.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Roche Holdings Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Medtronic plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Eli Lilly and Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Subcutaneous Drug Delivery Devices Market Other Major And Innovative Companies

31.1. Amgen Inc.
31.2. Novo Nordisk A/S
31.3. Becton Dickinson and Company
31.4. West Pharmaceutical Services Inc.
31.5. Gerresheimer AG
31.6. Insulet Corporation
31.7. SHL Medical AG
31.8. Tandem Diabetes Care Inc.
31.9. Ypsomed Holding AG
31.10. Nemera
31.11. Elcam Medical Ltd.
31.12. Owen Mumford Ltd.
31.13. Haselmeier GmbH
31.14. Sensile Medical AG
31.15. Enable Injections Inc.

32. Global Subcutaneous Drug Delivery Devices Market Competitive Benchmarking

33. Global Subcutaneous Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Subcutaneous Drug Delivery Devices Market

35. Subcutaneous Drug Delivery Devices Market Future Outlook and Potential Analysis

35.1 Subcutaneous Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
35.2 Subcutaneous Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
35.3 Subcutaneous Drug Delivery Devices Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer